Successful Treatment of Refractory Extensive Pityriasis Rubra Pilaris With Risankizumab and Acitretin

Cutis. 2024 Aug;114(2):E37-E39. doi: 10.12788/cutis.1096.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acitretin* / administration & dosage
  • Acitretin* / therapeutic use
  • Antibodies, Monoclonal* / administration & dosage
  • Antibodies, Monoclonal* / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Keratolytic Agents* / administration & dosage
  • Keratolytic Agents* / therapeutic use
  • Male
  • Pityriasis Rubra Pilaris* / drug therapy
  • Treatment Outcome

Substances

  • Acitretin
  • risankizumab
  • Keratolytic Agents
  • Antibodies, Monoclonal